HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

New-onset atrial fibrillation in patients with acute kidney injury on continuous renal replacement therapy.

AbstractPURPOSE:
The mortality of critically ill patients with acute kidney injury (AKI) who require continuous renal replacement therapy (CRRT) remains high. We assessed the incidence and predictors of new-onset atrial fibrillation (NOAF) in this population and its impact on outcomes.
MATERIALS AND METHODS:
This is a retrospective cohort study of adult intensive care units (ICU) patients who had AKI and received CRRT from December 2006 through November 2015 in a tertiary academic medical center. Cox proportional hazard model was used to evaluate the impact of NOAF on overall mortality.
RESULTS:
Out of 1398 screened patients, NOAF occurred in 193 (14%) cases. NOAF occurring on CRRT was independently associated with an increased hazard of death at follow-up (HR: 1.26; 95% CI: 1.03-1.56), compared to the group who did not have NOAF. In the multivariable analysis using time-dependent covariates, higher potassium (HR 1.24, 95%CI: 1.01-1.54) and bicarbonate (HR 0.95, 95%CI: 0.92-0.98) levels were associated with increased and decreased risk of NOAF on CRRT, respectively.
CONCLUSIONS:
NOAF in critically ill patients with AKI receiving CRRT is common and carries an unfavorable prognosis. Prospective studies are required to elucidate modifiable risk factors for NOAF occurring on CRRT.
AuthorsKhaled Shawwa, Panagiotis Kompotiatis, Shane A Bobart, Kristin C Mara, Brandon M Wiley, Jacob C Jentzer, Kianoush B Kashani
JournalJournal of critical care (J Crit Care) Vol. 62 Pg. 157-163 (04 2021) ISSN: 1557-8615 [Electronic] United States
PMID33383309 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2020 Elsevier Inc. All rights reserved.
Topics
  • Acute Kidney Injury (epidemiology, therapy)
  • Adult
  • Atrial Fibrillation (epidemiology, therapy)
  • Continuous Renal Replacement Therapy
  • Critical Illness
  • Humans
  • Intensive Care Units
  • Renal Replacement Therapy
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: